Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells

Bioconjugate Chemistry

Volumn 14, Issue 1, 2003, Pages 44-50

  Nori, Aparna ^a   Jensen, Keith D ^a   Tijerina, Monica ^a   Kopečková, Pavla ^a,b   Kopeček, Jindřich ^b  

^a UNIVERSITY OF UTAH   (United States)

^b University of Utah   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; FLUORESCENCE MICROSCOPY; FUNCTIONAL POLYMERS; MACROMOLECULES; PEPTIDES; TARGETED DRUG DELIVERY;

CELL-PENETRATING PEPTIDE; CONFOCAL FLUORESCENCE MICROSCOPY; CYTOPLASMIC DELIVERY; LIVE CELL MICROSCOPY; METHACRYLAMIDES; OVARIAN CARCINOMA CELL; SUBCELLULAR DISTRIBUTION; SUBCELLULAR FRACTIONATION; SYNTHESISED; SYNTHETIC MACROMOLECULES;

MOLECULAR BIOLOGY;

DOXORUBICIN; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL FRACTIONATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIVER CELL; MACROMOLECULE; OVARY CARCINOMA;

EID: 0037255080     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0255900     Document Type: Article

References (21)

1. Putnam, D.; Kopeček, J. (1995) Polymer conjugates with anticancer activity. Adv. Polym. Sci. 122, 55-123.
2. Kopeček, J., Kopečková, P., Minko, T., and Lu, Z-R. (2000) HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur. J. Pharm. Biopharm. 50, 61-81.
3. Kopeček, J., Rejmanová, P., Strohalm, J., Ulbrich, K., Říhová, B., Chytrý, V., Lloyd, J. B., and Duncan, R. (1991) Synthetic polymeric drugs. US Patent 5,037,883.
4. Lindgren, M., Hallbrink, H., Prochiantz, A., and Langel, U. (2000) Cell penetrating peptides. Trends Pharmacol. Sci. 21, 99-103.
5. Vivès, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
6. Schwarze, S. R., Hruska, K., and Dowdy, S. F. (2000) Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10, 290-295.
7. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
8. Green, M., and Loewenstein, P. M. (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 55, 1179-1188.
9. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 3, 1569-1572.
10. Lewin, M., Carlesso, N., Tung, C. H., Tang, X. W., Cory, D., Scadden, D. T., et al. (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414.
11. Polyakov, V., Sharma, V., Dahlheimer, J. L., Pica, C. M., Luker, G. D., and Piwnica-Worms, D. (2000) Novel Tatpeptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjugate Chem. 11, 762-771.
12. Astriab-Fisher, A., Sergueev, D., Fisher, M., Ramsay Shaw, B., and Juliano, R. L. (2002) Conjugates of antisense oligonucleotides with the Tat and Antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19, 744-754.
13. Eguchi, A., Akuta, T., Okuyama, H., Senda, T., Yokoi, H., Inokuchi, H. et al. (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276, 26204-26210.
14. Torchilin, V. P., Rammohan, R., Weissig, V., and Levchenko, T. S. (2001) Tat peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98, 8786-8791.
15. Niesner, U., Halin, C., Lozzi, L., Günthert, M., Neri, P., Wunderli-Allenspach, H. et al. (2002) Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides. Bioconjugate Chem. 13, 729-736.
16. Ulbrich, K., Šubr, V., Strohalm, J., Plocová, D., Jelínková, M., and Říhová, B. (2000) Polymeric drugs based on conjugates of synthetic and natural macromolecules I. Synthesis and physico-chemical characterization. J. Controlled Release. 64, 63-79.
17. Jensen, K. D., Kopečková, P., Bridge, J. H. B.; Kopeček, J. (2001) The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells. AAPS Pharm. Sci [serial online] 3, Article 32.
18. Omelyanenko, V., Kopečková, P., Gentry, C.; Kopeček, J. (1998) Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J. Controlled Release. 53, 25-37.
19. Duncan, R., and Lloyd, J. B. (1978) Pinocytosis in the rat visceral yolk sac. Effects of temperature, metabolic inhibitors and some other modifiers. Biochim, Biophys. Acta 544, 647-655.
20. Lundberg, M., and Johansson, M. (2002) Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 22, 367-371.
21. Tijerina, M., Kopečková, P., and Kopeček, J. (2002) unpublished results.